HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Payments, Folic Acid Recommendation: Health & Wellness Industry News Roundup

This article was originally published in The Rose Sheet

Executive Summary

Herbalife checks in the mail from FTC; PSTF recommends daily folic acid supplementation; OmniActive acquires ingredient firm Indfrag; and Vancouver firm prepares to launch 40J's products

You may also be interested in...



Herbalife Under SEC Scrutiny On Regulatory Compliance In China

Herbalife is the focus of a Securities and Exchange Commission investigation into anti-corruption compliance in the firm’s China business, the company reported in a Jan. 20 regulatory filing. An analyst covering the stock believes the investigation will have little impact on growth.

Warning, Conviction, Investment: Health & Wellness Industry News Roundup

Another supplement own-labeler warned; 11-year sentence in ephedrine case; and $35m investment in OmniActive.

Vemma's FTC Settlement Points Out Pyramid Scheme Charge

FTC makes clear in the settlement that Vemma was charged with violations including "operating an unlawful pyramid scheme" and that it agreed to compensate its independent distributors only for retail sales. "There have to be real sales to real people," says FTC attorney Lois Greisman.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109012

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel